Cargando…
Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016)
OBJECTIVES: We sought to determine the unique and shared contributions of clinical, neurocognitive and demographic factors to functional impairment in a large, transdiagnostic, clinical cohort of adolescents and young adults. DESIGN: Cross-sectional baseline data from a prospective, cohort study. SE...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303611/ https://www.ncbi.nlm.nih.gov/pubmed/30567821 http://dx.doi.org/10.1136/bmjopen-2018-022659 |
_version_ | 1783382199456759808 |
---|---|
author | Lee, Rico S C Hermens, Daniel F Naismith, Sharon L Kaur, Manreena Guastella, Adam J Glozier, Nick Scott, Jan Scott, Elizabeth M Hickie, Ian B |
author_facet | Lee, Rico S C Hermens, Daniel F Naismith, Sharon L Kaur, Manreena Guastella, Adam J Glozier, Nick Scott, Jan Scott, Elizabeth M Hickie, Ian B |
author_sort | Lee, Rico S C |
collection | PubMed |
description | OBJECTIVES: We sought to determine the unique and shared contributions of clinical, neurocognitive and demographic factors to functional impairment in a large, transdiagnostic, clinical cohort of adolescents and young adults. DESIGN: Cross-sectional baseline data from a prospective, cohort study. SETTING: Help-seeking youth referred from outpatient services were recruited to the Brain and Mind Youth Cohort (2008–2016) in Sydney, Australia. PARTICIPANTS: In total, 1003 outpatients were recruited, aged between 12 and 36 years (mean= 20.4 years, 54% female), with baseline diagnoses of affective, psychotic, developmental or behavioural disorders. INTERVENTIONS: Treatment as usual. PRIMARY OUTCOME MEASURES: Social and occupational functioning was used to index level of functional impairment. Structural equation modelling was used to examine associations between neurocognition, core clinical symptoms and alcohol and substance use, and clinician-rated and researcher-rated functional impairment. Moderator analyses were conducted to determine the potential influence of demographic and clinical factors (eg, medication exposure). RESULTS: Independent of diagnosis, we found that neurocognitive impairments, and depressive, anxiety and negative symptoms, were significantly associated with functioning. The association of neurocognition with social and occupational functioning remained significant even when constraining for age (15–25-year-olds only) or diagnosis (affective disorders only) in the final model. CONCLUSIONS: This study demonstrated that, in a clinically representative sample of youth, the key determinants of functioning may not be disorder specific. Further, evidence of neurocognitive dysfunction suggests that interventions that target cognition and functioning should not necessarily be reserved just for older adults with established illness. |
format | Online Article Text |
id | pubmed-6303611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-63036112019-01-04 Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) Lee, Rico S C Hermens, Daniel F Naismith, Sharon L Kaur, Manreena Guastella, Adam J Glozier, Nick Scott, Jan Scott, Elizabeth M Hickie, Ian B BMJ Open Mental Health OBJECTIVES: We sought to determine the unique and shared contributions of clinical, neurocognitive and demographic factors to functional impairment in a large, transdiagnostic, clinical cohort of adolescents and young adults. DESIGN: Cross-sectional baseline data from a prospective, cohort study. SETTING: Help-seeking youth referred from outpatient services were recruited to the Brain and Mind Youth Cohort (2008–2016) in Sydney, Australia. PARTICIPANTS: In total, 1003 outpatients were recruited, aged between 12 and 36 years (mean= 20.4 years, 54% female), with baseline diagnoses of affective, psychotic, developmental or behavioural disorders. INTERVENTIONS: Treatment as usual. PRIMARY OUTCOME MEASURES: Social and occupational functioning was used to index level of functional impairment. Structural equation modelling was used to examine associations between neurocognition, core clinical symptoms and alcohol and substance use, and clinician-rated and researcher-rated functional impairment. Moderator analyses were conducted to determine the potential influence of demographic and clinical factors (eg, medication exposure). RESULTS: Independent of diagnosis, we found that neurocognitive impairments, and depressive, anxiety and negative symptoms, were significantly associated with functioning. The association of neurocognition with social and occupational functioning remained significant even when constraining for age (15–25-year-olds only) or diagnosis (affective disorders only) in the final model. CONCLUSIONS: This study demonstrated that, in a clinically representative sample of youth, the key determinants of functioning may not be disorder specific. Further, evidence of neurocognitive dysfunction suggests that interventions that target cognition and functioning should not necessarily be reserved just for older adults with established illness. BMJ Publishing Group 2018-12-18 /pmc/articles/PMC6303611/ /pubmed/30567821 http://dx.doi.org/10.1136/bmjopen-2018-022659 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Mental Health Lee, Rico S C Hermens, Daniel F Naismith, Sharon L Kaur, Manreena Guastella, Adam J Glozier, Nick Scott, Jan Scott, Elizabeth M Hickie, Ian B Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title | Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title_full | Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title_fullStr | Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title_full_unstemmed | Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title_short | Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008–2016) |
title_sort | clinical, neurocognitive and demographic factors associated with functional impairment in the australian brain and mind youth cohort study (2008–2016) |
topic | Mental Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303611/ https://www.ncbi.nlm.nih.gov/pubmed/30567821 http://dx.doi.org/10.1136/bmjopen-2018-022659 |
work_keys_str_mv | AT leericosc clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT hermensdanielf clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT naismithsharonl clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT kaurmanreena clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT guastellaadamj clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT gloziernick clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT scottjan clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT scottelizabethm clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 AT hickieianb clinicalneurocognitiveanddemographicfactorsassociatedwithfunctionalimpairmentintheaustralianbrainandmindyouthcohortstudy20082016 |